Related Experiment Video
Updated: Oct 5, 2025

07:35
Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli
Published on: June 9, 2014
22.0K
Cleavable Self-Aggregating Tags (cSAT) for Therapeutic Peptide Expression and Purification
Xiaofeng Yang1, Zhanglin Lin2, Yanyun Jing3
1School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China. biyangxf@scut.edu.cn.
Methods in Molecular Biology (Clifton, N.J.)
|January 28, 2022
Summary
A new cleavable self-aggregating tag (cSAT) method efficiently produces therapeutic peptides. This cost-effective strategy uses self-assembling peptides and intein cleavage for purification, yielding authentic N-termini.
Area of Science:
- Biotechnology
- Protein and Peptide Engineering
- Biochemistry
Background:
- Therapeutic peptides are crucial but challenging to produce biologically.
- Existing methods struggle with unstable or difficult-to-express peptides.
- Need for efficient and cost-effective peptide production technologies.
Purpose of the Study:
- To develop a facile, reliable, and cost-effective peptide production and purification strategy.
- To enable the expression and purification of therapeutic peptides with authentic N-termini.
- To address challenges in producing peptides prone to degradation.
Main Methods:
- Utilized short self-assembling peptides (e.g., L6KD) and a C-terminal cleavage intein (e.g., Mtu ΔI-CM).
- Developed a cleavable self-aggregating tag (cSAT) scheme for in vivo aggregate formation.
- Employed centrifugation for aggregate separation and pH-induced intein self-cleavage for peptide release.
Main Results:
- Achieved a yield of approximately 4.4 μg/mg wet cell pellet for the therapeutic peptide GLP-1.
- Demonstrated successful purification of peptides with authentic N-termini.
- Validated the cSAT strategy for peptides in the 30-100 amino acid range.
Conclusions:
- The cSAT strategy offers a viable approach for producing peptides, especially those difficult to express.
- This method is cost-effective and yields peptides with native N-termini.
- Facilitates the biotechnological production of therapeutic peptides previously limited by expression challenges.

